ArticleTrials2022

A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): a trial conducted within the VACCELERATE network.

Julia M Neuhann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.